Patents Assigned to IRIDEX
-
Patent number: 9278029Abstract: Embodiments of the invention provide systems and methods for treating the retina and/or other areas of a patient's eye. The procedures may involve using one or more treatment beams (e.g., lasers) to cause photocoagulation or laser coagulation to finely cauterize ocular blood vessels and/or prevent blood vessel growth to induce one or more therapeutic benefits. In other embodiments, a series of short duration light pulses (e.g., between 5-15 microseconds) may be delivered to the retinal tissue with a thermal relaxation time delay between the pulse to limit the temperature rise of the target retinal tissue and thereby limit a thermal effect to only the retinal pigment epithelial layer. Such procedures may be used to treat diabetic retinopathy, macular edema, and/or other conditions of the eye. The treatment beam may be delivered within a treatment boundary or pattern defined on the retina of the patient's eye.Type: GrantFiled: October 19, 2012Date of Patent: March 8, 2016Assignee: IRIDEX CorporationInventors: Kingman Yee, Dave Buzuwa
-
Patent number: 9265656Abstract: Embodiments of the invention provide systems and methods for treating the retina and/or other areas of a patient's eye. The procedures may involve using one or more treatment beams (e.g., lasers) to cause photocoagulation or laser coagulation to finely cauterize ocular blood vessels and/or prevent blood vessel growth to induce one or more therapeutic benefits. In other embodiments, a series of short duration light pulses (e.g., between 5-15 microseconds) may be delivered to the retinal tissue with a thermal relaxation time delay between the pulse to limit the temperature rise of the target retinal tissue and thereby limit a thermal effect to only the retinal pigment epithelial layer. Such procedures may be used to treat diabetic retinopathy, macular edema, and/or other conditions of the eye. The treatment beam may be delivered within a treatment boundary or pattern defined on the retina of the patient's eye.Type: GrantFiled: October 19, 2012Date of Patent: February 23, 2016Assignee: IRIDEX CorporationInventor: Kingman Yee
-
Patent number: 9241831Abstract: Drainage of aqueous from the anterior chamber of the eye can be facilitated by a malleable hollow clip or staple that can be formed to attach to ophthalmic tissue and provide intra-luminal flow of aqueous through the clip. In addition, the clip can be adjusted to modulate the outflow rate of aqueous, both during the initial surgical procedure as well as on a post-procedure basis. Furthermore, an instrument is described in which the forceps of the clip delivery device reside inside the lumen of hollow clip during deployment and manipulation. Features of an instrument are designed to secure the clip to the delivery forceps and prevent tissue blockage of the clip lumens. The clips may be color-matched to the underlying tissue for the purpose of camouflage and may carry pharmaceuticals.Type: GrantFiled: February 13, 2013Date of Patent: January 26, 2016Assignee: IRIDEX CorporationInventors: Kenneth A. Peartree, Tim Buckley, Aaron Feustel
-
Patent number: 9122131Abstract: The present invention generally relates to methods and devices for mounting an image capture device to an optical viewing instrument such as a microscope, telescope, or binocular. More specifically, some embodiments of the present invention relate to an apparatus for mounting a smart phone to an observation tube of microscope. The optical viewing instrument may have an observation tube and an ocular attached thereto. The adapter may include an observation tube ring mount configured to be installed on the observation tube. An observation tube mount may be configured to engage with the installed ring mount. An image capture device holder may be configured to couple with the observation tube mount and configured to receive an image capture device. The image capture device may be a common device such as a smart phone. Optionally, a window may be included in the observation tube mount to facilitate viewing of ocular indicia.Type: GrantFiled: September 6, 2013Date of Patent: September 1, 2015Assignee: IRIDEX CorporationInventors: Aaron Coppage, Alexander Fernandez
-
Patent number: 9004780Abstract: An identification assembly for use with a fiber-optic connector includes a non-conducting over-nut, an electrical assembly disposed at the proximal end of the over-nut, and an RFID tag supported by the distal end of the over-nut. The over-nut is configured to surround and couple with the fiber-optic connector. The electrical assembly includes a first electrical contact configured to electrically connect to the fiber-optic connector, a second electrical contact configured for electrical engagement with a contact portion of a light source assembly, and one or more electrical components coupled between the first and second contacts and providing a defined electrical characteristic. The identification assembly enables identification using either electrical-characteristic based or RFID-based identification approaches.Type: GrantFiled: September 24, 2013Date of Patent: April 14, 2015Assignee: IRIDEX CorporationInventors: Kingman Yee, Ronald Avisa
-
Patent number: 8945103Abstract: Systems, devices, and methods for treating a glaucomatous eye are provided. An amount of pulsed laser energy is delivered to the pars plana of the eye by a hand-holdable device which comprises a hand-holdable elongate member and a contact member disposed on an end of the elongate member. A contact surface of the contact member is placed in direct contact with the eye so that a reference edge of the contact member aligns with the limbus and a treatment axis defined by the elongate member is angularly offset from the optical axis of the eye. The amount of pulsed laser energy delivered is insufficient to effect therapeutic photocoagulation but is sufficient to increase uveoscleral outflow so as to maintain a reduction from pre-laser treatment intraocular pressure. Amounts of pulsed laser energy will be transmitted to a circumferential series of tissue regions of the eye.Type: GrantFiled: October 30, 2008Date of Patent: February 3, 2015Assignee: IRIDEX CorporationInventors: Paul T. K. Chew, David M. Buzawa, Giorgio Dorin
-
Publication number: 20140362283Abstract: The present invention generally relates to methods and devices for mounting an image capture device to an optical viewing instrument such as a microscope, telescope, or binocular. More specifically, some embodiments of the present invention relate to an apparatus for mounting a smart phone to an observation tube of microscope. The optical viewing instrument may have an observation tube and an ocular attached thereto. The adapter may include an observation tube ring mount configured to be installed on the observation tube. An observation tube mount may be configured to engage with the installed ring mount. An image capture device holder may be configured to couple with the observation tube mount and configured to receive an image capture device. The image capture device may be a common device such as a smart phone. Optionally, a window may be included in the observation tube mount to facilitate viewing of ocular indicia.Type: ApplicationFiled: September 6, 2013Publication date: December 11, 2014Applicant: IRIDEX CorporationInventors: Aaron Coppage, Alexander Fernandez
-
Publication number: 20140228824Abstract: The procedures described herein may involve using one or more treatment beams to induce one or more therapeutic benefits. In some embodiments, a series of short duration light pulses may be delivered to ocular tissue at a plurality of target locations with a thermal relaxation time delay to limit the temperature rise of the target ocular tissue and thereby limit a thermal effect to only a desired portion of the ocular tissue. The thermal relaxation time delay may be roughly equivalent to a duration of a scan of the treatment beam between each of the target locations. Such procedures may be used to treat diabetic retinopathy, macular edema, and/or other conditions of the eye. The treatment beam may be delivered at each target location within a sufficiently short duration so as to produce a visual appearance of a treatment pattern on the ocular tissue of the patient's eye.Type: ApplicationFiled: April 18, 2014Publication date: August 14, 2014Applicant: IRIDEX CorporationInventors: Kingman Yee, Ronald Avisa, Michael Miu
-
Publication number: 20140175157Abstract: Improved tissue fasteners are disclosed that can be inserted into (and optionally through) tissue structures underlying a tissue surface for affixing overlapping tissues and tissue planes together, and the like. In some embodiments, an elongate anvil body may protrude distally and/or laterally from a fastener support disposed along the base. The anvil body may have a sharpened end and be configured to penetrate into the tissue, with the elongate anvil body optionally having a bend from a more distal orientation adjacent the clip support to a more lateral orientation adjacent the sharpened end during at least a portion of the deployment. The first leg can be driven through a desired location on the surface of the first tissue and against a receptacle of the anvil body so as to deform the fastener and affix it to the first tissue.Type: ApplicationFiled: October 4, 2013Publication date: June 26, 2014Applicant: IRIDEX CorporationInventors: Steven D. Vold, Kenneth A. Peartree, Timothy D. Buckley, Aaron Feustel
-
Publication number: 20140086535Abstract: An identification assembly for use with a fiber-optic connector includes a non-conducting over-nut, an electrical assembly disposed at the proximal end of the over-nut, and an RFID tag supported by the distal end of the over-nut. The over-nut is configured to surround and couple with the fiber-optic connector. The electrical assembly includes a first electrical contact configured to electrically connect to the fiber-optic connector, a second electrical contact configured for electrical engagement with a contact portion of a light source assembly, and one or more electrical components coupled between the first and second contacts and providing a defined electrical characteristic. The identification assembly enables identification using either electrical-characteristic based or RFID-based identification approaches.Type: ApplicationFiled: September 24, 2013Publication date: March 27, 2014Applicant: Iridex CorporationInventors: Kingman Yee, Ronald Avisa
-
Publication number: 20140052046Abstract: Drainage of aqueous from the anterior chamber of the eye can be facilitated by a malleable hollow clip or staple that can be formed to attach to ophthalmic tissue and provide intra-luminal flow of aqueous through the clip. In addition, the clip can be adjusted to modulate the outflow rate of aqueous, both during the initial surgical procedure as well as on a post-procedure basis. Furthermore, an instrument is described in which the forceps of the clip delivery device reside inside the lumen of hollow clip during deployment and manipulation. Features of an instrument are designed to secure the clip to the delivery forceps and prevent tissue blockage of the clip lumens. The clips may be color-matched to the underlying tissue for the purpose of camouflage and may carry pharmaceuticals.Type: ApplicationFiled: February 13, 2013Publication date: February 20, 2014Applicant: IRIDEX CORPORATIONInventors: Kenneth A. Peartree, Tim Buckely, Aaron Feustel
-
Publication number: 20130168432Abstract: Improved tissue fasteners are disclosed that can be inserted into (and optionally through) tissue structures underlying a tissue surface, for affixing overlapping tissues and tissue planes together, and the like. In some embodiments, an elongate anvil body may protrude distally and/or laterally from a fastener support disposed along the base. The anvil body may have a sharpened end and be configured to penetrate into the tissue, with the elongate anvil body optionally having a bend from a more distal orientation adjacent the clip support to a more lateral orientation adjacent the sharpened end during at least a portion of the deployment. The first leg can be driven through a desired location on the surface of the first tissue and against a receptacle of the anvil body so as to deform the fastener and affix it to the first tissue.Type: ApplicationFiled: December 10, 2012Publication date: July 4, 2013Applicant: IRIDEX CorporationInventor: IRIDEX Corporation
-
Publication number: 20130116672Abstract: Embodiments of the invention provide systems and methods for treating the retina and/or other areas of a patient's eye. The procedures may involve using one or more treatment beams (e.g., lasers) to cause photocoagulation or laser coagulation to finely cauterize ocular blood vessels and/or prevent blood vessel growth to induce one or more therapeutic benefits. In other embodiments, a series of short duration light pulses (e.g., between 5-15 microseconds) may be delivered to the retinal tissue with a thermal relaxation time delay between the pulse to limit the temperature rise of the target retinal tissue and thereby limit a thermal effect to only the retinal pigment epithelial layer. Such procedures may be used to treat diabetic retinopathy, macular edema, and/or other conditions of the eye. The treatment beam may be delivered within a treatment boundary or pattern defined on the retina of the patient's eye.Type: ApplicationFiled: October 19, 2012Publication date: May 9, 2013Applicant: Iridex CorporationInventor: Iridex Corporation
-
Publication number: 20130110093Abstract: Embodiments of the invention provide systems and methods for treating the retina and/or other areas of a patient's eye. The procedures may involve using one or more treatment beams (e.g., lasers) to cause photocoagulation or laser coagulation to finely cauterize ocular blood vessels and/or prevent blood vessel growth to induce one or more therapeutic benefits. In other embodiments, a series of short duration light pulses (e.g., between 5-15 microseconds) may be delivered to the retinal tissue with a thermal relaxation time delay between the pulse to limit the temperature rise of the target retinal tissue and thereby limit a thermal effect to only the retinal pigment epithelial layer. Such procedures may be used to treat diabetic retinopathy, macular edema, and/or other conditions of the eye. The treatment beam may be delivered within a treatment boundary or pattern defined on the retina of the patient's eye.Type: ApplicationFiled: October 19, 2012Publication date: May 2, 2013Applicant: Iridex CorporationInventor: Iridex Corporation
-
Publication number: 20130110092Abstract: Embodiments of the invention provide systems and methods for treating the retina and/or other areas of a patient's eye. The procedures may involve using one or more treatment beams (e.g., lasers) to cause photocoagulation or laser coagulation to finely cauterize ocular blood vessels and/or prevent blood vessel growth to induce one or more therapeutic benefits. In other embodiments, a series of short duration light pulses (e.g., between 5-15 microseconds) may be delivered to the retinal tissue with a thermal relaxation time delay between the pulse to limit the temperature rise of the target retinal tissue and thereby limit a thermal effect to only the retinal pigment epithelial layer. Such procedures may be used to treat diabetic retinopathy, macular edema, and/or other conditions of the eye. The treatment beam may be delivered within a treatment boundary or pattern defined on the retina of the patient's eye.Type: ApplicationFiled: October 19, 2012Publication date: May 2, 2013Applicant: Iridex CorporationInventor: Iridex Corporation
-
Publication number: 20130110206Abstract: Embodiments of the invention provide systems and methods for treating the retina and/or other areas of a patient's eye. The procedures may involve using one or more treatment beams (e.g., lasers) to cause photocoagulation or laser coagulation to finely cauterize ocular blood vessels and/or prevent blood vessel growth to induce one or more therapeutic benefits. In other embodiments, a series of short duration light pulses (e.g., between 5-15 microseconds) may be delivered to the retinal tissue with a thermal relaxation time delay between the pulse to limit the temperature rise of the target retinal tissue and thereby limit a thermal effect to only the retinal pigment epithelial layer. Such procedures may be used to treat diabetic retinopathy, macular edema, and/or other conditions of the eye. The treatment beam may be delivered within a treatment boundary or pattern defined on the retina of the patient's eye.Type: ApplicationFiled: October 19, 2012Publication date: May 2, 2013Applicant: Iridex CorporationInventor: Iridex Corporation
-
Patent number: 8177777Abstract: A surgical device having a body portion that is gripped by a user, the body portion having a distal end equipped with a soft tip and the proximal end optionally connected to an external vacuum or gas/air source. The surgical device is particularly suitable for use in ophthalmic surgical procedures to remove fluid from the eye or introduce gas/air into the eye. The soft tip is fabricated to protect the delicate tissues if the eye and is further modified so as to enhance a user's visibility of the device in the surgical field.Type: GrantFiled: April 21, 2009Date of Patent: May 15, 2012Assignee: Iridex CorporationInventor: Mark S. Humayun
-
Patent number: 7909816Abstract: A treatment apparatus includes a cannula with a cannula lumen. The cannula has a first average diameter. A probe is positionable in the cannula lumen. The probe has a first section with a second average diameter and a second section with a third average diameter that is less than the second average diameter. At least a portion of the second section has a curved section with at least one radius of curvature. The radius of curvative is selected to provide that as the second section passes through the cannula lumen a first side of the second section is tangential to a first side of the cannula lumen, and a second opposing side of the second section is tangential to a second opposing side of the cannula lumen.Type: GrantFiled: August 16, 2005Date of Patent: March 22, 2011Assignee: Iridex CorporationInventor: David M. Buzawa
-
Patent number: 7771417Abstract: A laser system that includes a diode pump source. A frequency doubled solid state visible laser is pumped by the diode pump source and produces a pulsed laser output with a train of pulses. Resources provide instructions for the creation of the pulsed output, with on and off times that provide for substantial confinement of thermal effects at a target site. This laser system results in tissue specific photoactivation (or TSP) without photocoagulation damage to any of the adjacent tissues and without causing full thickness retinal damage and the associated vision loss.Type: GrantFiled: February 24, 2005Date of Patent: August 10, 2010Assignee: IRIDEX CorporationInventors: William Telfair, Ronald Avisa, Stuart Mohr, David M. Buzawa
-
Patent number: 7766904Abstract: A laser probe including a handpiece and a rigid cannula fixed to the handpiece to prevent relative translational movement-therebetween. An optical fiber for delivering laser energy is supported for translational movement relative to the handpiece. A slidable button is fixed to the optical fiber via a rigid sleeve such that the button and optical fiber move together in the same direction during operation. The fiber may be selectively positioned relative to the button to cause the button to act as a visual indicator of the direction in which the fiber will extend from the cannula. The button may be specially configured with an enlarged head portion to enhance grippability and smooth operation of the button.Type: GrantFiled: January 14, 2005Date of Patent: August 3, 2010Assignee: IRIDEX CorporationInventors: Michael J. Mc Gowan, Sr., Charles R. Hurst, Jr., Harry Michael Lambert, Christopher F. Lumpkin